TLE1 function and therapeutic potential in cancer

18Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Groucho (Gro)/Transducin-like enhancer of split (TLE) family proteins act as corepressors of many transcription factors, and are involved in key signaling pathways. TLE1 negatively regulates inflammation and has potential roles in various diseases, including cancer. Previous studies suggest TLE1 could be used as a diagnostic marker and is a possible therapeutic target in various malignancies. It is therefore important to elucidate the mechanisms underlying TLE1 function during cancer initiation and metastasis. In this review, we highlight the functions of TLE1 in cancer and explore targeted approaches for cancer diagnosis and treatment. In particular, we discuss the TLE1 function in pancreatic cancer.

Cite

CITATION STYLE

APA

Yuan, D., Yang, X., Yuan, Z., Zhao, Y., & Guo, J. (2017). TLE1 function and therapeutic potential in cancer. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.13278

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free